Young I. Koh
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
REG4 serves as a prognostic biomarker for pancreatic cancer with long-standing diabetes mellitus by modulating chemoresistance.
Journal: Translational oncology
Published: May 06, 2026
HAP1 interaction with KCNQ4 attenuates channel surface expression and function.
Journal: Molecules and cells
Published: October 01, 2025
MYH1 deficiency disrupts outer hair cell electromotility, resulting in hearing loss.
Journal: Experimental & molecular medicine
Published: March 04, 2024
Overlooked KCNQ4 variants augment the risk of hearing loss.
Journal: Experimental & molecular medicine
Published: August 16, 2022
OSBPL2 mutations impair autophagy and lead to hearing loss, potentially remedied by rapamycin.
Journal: Autophagy
Published: March 07, 2022
COCH-related autosomal dominant nonsyndromic hearing loss: a phenotype-genotype study.
Journal: Human genetics
Published: April 20, 2021
Differential genetic diagnoses of adult post-lingual hearing loss according to the audiogram pattern and novel candidate gene evaluation.
Journal: Human genetics
Published: March 25, 2021
Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
Journal: Experimental & molecular medicine
Published: February 21, 2021
Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment.
Journal: Experimental & molecular medicine
Published: October 22, 2018
A recurrent mutation in KCNQ4 in Korean families with nonsyndromic hearing loss and rescue of the channel activity by KCNQ activators.
Journal: Human mutation
Published: July 10, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026